PNPLA3 and metabolic dysfunction-associated steatotic liver disease: These single nucleotide polymorphisms have been identified as significant factors influencing the outcomes of MASLD and, in some cases (e.g., PNPLA3 and HSD17B13 genes), of ALD and the risk of increased liver fibrosis and progression to end‐stage liver disease [54].